Currently out of the existing stock ratings of Kristen Stewart, 57 are a BUY (58.76%), 14 are a SELL (14.43%), 26 are a HOLD (26.8%).

Kristen Stewart

Work Performance Price Targets & Ratings Chart

Analyst Kristen Stewart, carries an average stock price target met ratio of 79.45% that have a potential upside of 19.86% achieved within 370 days. Previously, Kristen Stewart worked at C. L. KING.

Kristen Stewart’s has documented 183 price targets and ratings displayed on 17 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on TFX, Teleflex at 03-Nov-2024.

Wall Street Analyst Kristen Stewart

Analyst best performing recommendations are on AVNS (AVANOS MEDICAL).
The best stock recommendation documented was for AVNS (AVANOS MEDICAL) at 4/13/2020. The price target of $30 was fulfilled within 1 day with a profit of $1.62 (5.71%) receiving and performance score of 57.08.

Average potential price target upside

of $49.91 (26.76%) on BDX (BECTON DICKINSON AND COMPANY).
of $37.16 (38.08%) on JNJ (JOHNSON & JOHNSON).
of $32.54 (47.73%) on MDT (MEDTRONIC PLC).

ABT Abbott Laboratories BAX Baxter International BDX Becton Dickinson and Company BSX Boston Scientific Corp CNMD CONMED EW Edwards Lifesciences Corp HRC Hill-Rom Holdings JNJ Johnson & Johnson MDT Medtronic PLC SYK Stryker TFX Teleflex TNDM Tandem Diabetes Care ZBH Zimmer Biomet Holdings AVNS Avanos Medical CSII Cardiovascular Systems SILK Silk Road Medical AXNX Axonics Modulation Technologies

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Matt Miksic (BARCLAYS)